The Global Challenges Research Fund (GCRF) funded nine Networks. Members of ANTI-VeC can sign up to and work with members across the other funded Networks.
Vector-borne Disease Research Networks:
The Application of Novel Transgenic technology & Inherited symbionts to Vector Control (ANTI-VeC) network.
The Building out Vector-Borne Diseases in sub-Saharan Africa (BOVA) network. BOVA aims to stimulate research in the area of vector-borne diseases and the built environment.
The Community Network for African Vector-Borne Plant Viruses (CONNECTED) network, which aims to build a sustainable network of international scientists and researchers to address the challenges of vector-borne plant viruses in Africa.
The Gnatwork brings together workers on blackflies (Simulidae), sandflies (Psychodidae) and biting midges (Ceratopogonidae) from around the world to address technical issues that arise when working on small biting flies. We aim to support and develop early career researchers working on these insects in countries receiving official development assistance (ODA) and also carry out high quality studies that will underpin future research efforts on these vectors.
HIC-VAC: Human Challenge Model Network aims to support, develop and advocate for human infection challenge studies (HIC) to accelerate the development of vaccines against pathogens of high global impact. This Network will enable open sharing of knowledge and expertise, using Network resources to increase HIC use in the UK and LMICs, disseminating best practice, enhancing training and fostering new collaborative studies relevant to high-impact pathogens.
VALIDATE: Vaccine deveLopment for complex Intracellular neglecteD pAThogEns Network aims to promote vaccine R&D for complex intracellular pathogens that cause significant disease burden in LMICs. The initial focus is on Mycobacterium tuberculosis (which causes TB), Leishmania species (leishmaniasis), Burkholderia pseudomallei (melioidosis) and Mycobacterium leprae (leprosy). The Network is creating an engaged and interactive community of researchers who are forming new cross-pathogen, cross-continent, cross-species and cross-discipline collaborations, generating new ideas, taking advantage of synergies and quickly disseminating lessons learned across the Network, with the aim of together making significant progress towards vaccines against the focus pathogens. Key interests are in-vivo research, cross-pathogen studies, projects promoting the One Health agenda, and collaborative projects involving LMICs and Early Career researchers.
IMPRINT: IMmunising PRegnant women and INfants Network aims to build a sustainable Network of stakeholders from basic science, immunology, vaccinology, social sciences, industry, public health, national and international policy makers, to increase protection from infection in neonates via the safe and effective use of vaccines in pregnancy and in newborns. The Network will nurture discovery and implementation science in close collaboration with sites and investigators in LMICs, including via an IMPRINT fellowship scheme.
BactiVac: The Bacterial Vaccines Network will accelerate the development of vaccines against bacterial infections, particularly those relevant to LMICs. The BactiVac Network will bring together academic, industrial and other partners involved in vaccine research against human and animal bacterial infections from the UK and LMICs. The Network will foster partnership and provide catalyst project and training funding to encourage cross-collaboration between academic and industrial partners.
IVVN: International Veterinary Vaccinology Network is a multidisciplinary community passionate about developing vaccines to improve animal and human health. The Network will facilitate the formation of international collaborations to improve vaccine design and development for livestock and zoonotic diseases in low-and-middle income countries (LMICs). Furthermore, the International Veterinary Vaccinology Network will bring together researchers from across the fields of veterinary and human vaccinology, irrespective of pathogen or species of interest, with the aim of addressing key bottlenecks that are preventing vaccine development for important pathogens of livestock in LMICs.